Cancer-associated pulmonary embolism — SCE Respiratory MCQ
Instant feedback + full explanation. One question, done properly.
Educational content. Not a substitute for clinical judgement or local policy.
Reveal the answer and explanation
Correct answer: D — Therapeutic cancer-associated anticoagulation
Active cancer-associated PE requires therapeutic anticoagulation, using LMWH or an appropriate DOAC after reviewing bleeding risk and interactions. Aspirin is inadequate treatment for PE. Thrombolysis is reserved for high-risk PE with haemodynamic compromise, not stable cancer-associated PE.
Reference: NICE NG158; BNF Anticoagulants: https://www.nice.org.uk/guidance/ng122